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Presidential Address 1 Cardiothoracic surgery: A specialty divided or as one
Douglas E. Wood, MD, Seattle, Wash
Expert Commentary 10 Esophagectomy volume threshold as a criterion for centers of excellence:
Causation or cause, strategy or strategem?:
Thomas W. Rice, MD, and Eugene H. Blackstone, MD, Cleveland, Ohio
Point/Counterpoint 13 POINT: Clinical stage IA non–small cell lung cancer determined by computed
tomography and positron emission tomography is frequently not pathologic IA
non–small cell lung cancer: The problem of understaging
Brendon M. Stiles, MD, Elliot L. Servais, MD, Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto Paul,
MD, and Nasser K. Altorki, MD, New York, NY
Clinical stage IA lung cancer determined preoperatively by the combination of CT and PET scan is
frequently understaged. Of 266 patients identified, lung cancer was correctly staged in only 65%. Size
greater than 2 cm and PET positivity are risk factors for understaging. Limited resection should be
undertaken with caution in such patients.
20 COUNTERPOINT: Despite staging inaccuracies, patients with non–small cell
lung cancer are best served by having integrated positron emission tomography/
computed tomography before therapy:
Robert J. Cerfolio, MD, FACS, FCCP, Birmingham, Ala
Although integrated PET/CT suffers from false negative and false positive results, if biopsy tissue is
obtained from all suspicious sites and assumptions are not made, PET provides the best staging and
treatment for patients with NSCLC. If thoracotomy, lung palpation, pulmonary resection, and
lymphadenectomy are performed, PET misstaging is probably irrelevant.
General Thoracic
Surgery (GTS)
23 The effect of volume on esophageal cancer resections: What constitutes
acceptable resection volumes for centers of excellence?:
Robert A. Meguid, MD, MPH, Eric S. Weiss, MD, David C. Chang, PhD, MPH, MBA,
Malcolm V. Brock, MD, and Steven C. Yang, MD, Baltimore, Md
Volume–outcome relationships for esophageal cancer resection have been well described, but no
consensus exists for what constitutes a ‘‘high-volume’’ center. On statistical determination of an
appropriate volume optimized for outcome, we have determined that volume cutoff alone is
insufficient for defining centers of excellence.
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CSP30 A thoracic surgery clinic dedicated to indeterminate pulmonary nodules: Too
many scans and too little pathology?
Nirmal K. Veeramachaneni, MD, Traves D. Crabtree, MD, Daniel Kreisel, MD, PhD,
Jennifer B. Zoole, BSN, Joanne F. Musick, BSN, Nicole G. Taylor, APRN, Alexander S. Krupnick, MD,
David S. Gierada, MD, G. Alexander Patterson, MD, and Bryan F. Meyers, MD, MPH,
St Louis, Mo
The creation of a clinic dedicated to the evaluation of patients with indeterminate nodules resulted in
few diagnoses of malignancy. Very few patients were treated for cancer, and many patients required
continued follow-up for development of new nodules.
36 Health-related quality of life in esophageal cancer: Effect of neoadjuvant
chemoradiotherapy followed by surgical intervention
Najib Safieddine, MD, Wei Xu, PhD, Sayed Mohammed Quadri, MD, FRCSC, Jennifer J. Knox, MD,
FRCP, Jennifer Hornby, BSc, CCRP, Joanne Sulman, MSW, Rebecca Wong, MD, FRCP,
Maha Guindi, MD, FRCP, Shaf Keshavjee, MD, MSc, FRCSC, FACS, and Gail Darling, MD,
FRCSC, FACS, Toronto, Ontario, Vancouver, and British Columbia, Canada
Neoadjuvant chemoradiotherapy followed by surgical intervention for esophageal cancer has
a significant effect on health-related quality of life (HRQOL). This effect, however, is transient, and
patients’ HRQOL scores return to baseline within 3 months postoperatively. Increasing Functional
Assessment of Cancer Therapy–Esophageal scores postoperatively over time were predictive of
improved survival.
43 Fluorodeoxyglucose positron emission tomography and tumor marker
expression in non–small cell lung cancer
Matthew D. Taylor, MD, Philip W. Smith, MD, William K. Brix, MD, Mark R. Wick, MD,
Nicholas Theodosakis, Brian R. Swenson, MD, MS, Benjamin D. Kozower, MD,
Christine L. Lau, MD, and David R. Jones, MD, Charlottesville, Va
FDG–PET SUVmax correlates with an increased expression of GLUT-1 and p53 in adenocarcinoma
and EGFR in all NSCLC samples. GLUT-1 expression in NSCLC is significantly greater in regional
node–positive disease. SUVmax was significantly greater in patients with nodal disease associated
with tumor expression of GLUT-1, p53, or cyclin D1.
49 Salvage esophagectomy after high-dose chemoradiotherapy for esophageal
squamous cell carcinoma
Yuji Tachimori, MD, Norio Kanamori, MD, Norihisa Uemura, MD, Norikazu Hokamura, MD,
Hiroyasu Igaki, MD, and Hoichi Kato, MD, Tokyo, Japan
Morbidity and mortality rates are increased in patients who undergo salvage esophagectomy after
definitive high-dose chemoradiotherapy. Tracheobronchial necrosis and gastric conduit necrosis are
highly lethal complications after salvage esophagectomy.The 3-year postoperative survival of 38%would
nevertheless be acceptable relative to the potential long-term survival after salvage esophagectomy.
55 Factors predictive of prognosis after esophagectomy for squamous cell cancer
Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang Wei, and
Guoren Zhou, MS, Nanjing, China
Several pathologic characteristics of the primary tumor are correlatedwith the outcome of esophagectomy
for SCC of the thoracic esophagus. Patients with fewer than 2 metastatic nodes after curative
esophagectomy have a better prognosis than thosewithmultiple involved nodes (.2). To stratify patients
appropriately for prognosis, it is necessary to refine the current 6th edition TNM staging system.
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60 The impact of placing multiple grafts to each myocardial territory on long-term
survival after coronary artery bypass grafting
Danny Chu, MD, Faisal G. Bakaeen, MD, Xing Li Wang, MD, PhD, Joseph S. Coselli, MD,
Scott A. LeMaire, MD, and Joseph Huh, MD, Houston, Tex
We studied outcomes of coronary artery bypass grafting in patients who received single (n 5 580)
or multiple (n 5 549) grafts to each major diseased artery territory. Patients who received multiple
grafts per territory had longer operative times. Groups had similar early outcomes and long-term
survivals.
65 Improved quality and cost-effectiveness of coronary artery bypass grafting in
the United States from 1988 to 2005
Howard K. Song, MD, PhD, Brian S. Diggs, PhD, Matthew S. Slater, MD, Steven W. Guyton, MD,
MHA, Ross M. Ungerleider, MD, MBA, and Karl F. Welke, MD, Portland, Ore
CABG is performed on an increasingly high-risk patient population in the United States. Despite this
challenge, risk-adjusted operative mortality and hospital charges for CABG in relation to other
medical care services have been reduced. These findings reflect substantially improved quality and
cost-effectiveness of CABG in the United States.
70 Early and late outcomes in minimally invasive mitral valve repair: An
eleven-year experience in 707 patients
R. Scott McClure, MD, SM, Lawrence H. Cohn, MD, Esther Wiegerinck, Gregory S. Couper, MD,
Sary F. Aranki, MD, R. Morton Bolman, III, MD, Michael J. Davidson, MD, and Frederick Y. Chen,
MD, Boston, Mass
Minimally invasive mitral valve repair has been proven safe with low perioperative morbidity,
but long-term outcomes have not been sufficiently assessed. We report 11-year outcome data on
morbidity, mortality, rates of reoperation, and valve integrity via echocardiography for a large
minimally invasive mitral valve series.
76 A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis
Pia S. U. Myke´n, MD, PhD, and Odd Bech-Hansen, MD, PhD, Gothenburg, Sweden
The 20-year data on the ongoing long-term study of the St Jude Medical Biocor (St Jude Medical,
St Paul, Minn) porcine prosthesis are presented for 1712 patients who underwent valve
replacements at Sahlgrenska University Hospital (Sweden) between 1983 and 2003. The 20-year
data confirmed the excellent valve durability reported at the 17-year follow-up using this
bioprosthesis.
82 Isolated aortic valve replacement in North America comprising 108,687 patients
in 10 years: Changes in risks, valve types, and outcomes in the Society of
Thoracic Surgeons National Database
James M. Brown, MD, Sean M. O’Brien, PhD, Changfu Wu, PhD, Jo Ann H. Sikora, CRNP,
Bartley P. Griffith, MD, and James S. Gammie, MD, Baltimore, Md, and Durham, NC
The Society of Thoracic Surgeons Database was used to examine both characteristics of patients
undergoing aortic valve replacement during the last 10 years and how those characteristics and
outcome measures have changed with that time. Although risks have increased, outcomes have
improved.
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CSP91 Incidence of thromboembolic complications in patients with mechanical heart
valves with a subtherapeutic international normalized ratio
Francesco Dentali, MD, Nicoletta Riva, MD, Alessandra Malato, MD, Giorgia Saccullo, MD,
Sergio Siragusa, MD, and Walter Ageno, MD, Varese and Palermo, Italy
Subtherapeutic international normalized ratios are frequently encountered clinically. Because
there are no data on risk of thromboembolic events for patients with mechanical heart valves,
we assessed this risk, evaluating rate of thromboembolic events at 90-day follow-up in 294
consecutive patients with mechanical heart valves seen with subtherapeutic international
normalized ratios.
94 Postimplantation morphologic changes of glutaraldehyde-fixed porcine aortic
roots and risk of aneurysm and rupture
Tirone E. David, MD, Susan Armstrong, MSc, Manjula Maganti, MSc, Jagdish Butany, MD,
Christopher M. Feindel, MD, and Joanne Bos, RN, Toronto, Ontario, Canada
This study revealed that mild dilation of the aortic sinuses of porcine aortic roots used for aortic
root replacement is common but aneurysm formation, rupture, or both is rare during a mean
follow-up of 5.3 years. Larger valves and duration of follow-up increased the risk of dilation.
101 Ascending thoracic aortic aneurysms are associated with compositional
remodeling and vessel stiffening but not weakening in age-matched subjects
Dimitrios C. Iliopoulos, MD, PhD, Eleftherios P. Kritharis, BSc, Athina T. Giagini, MSc,
Stavroula A. Papadodima, MD, PhD, and Dimitrios P. Sokolis, PhD, Athens, Greece
Development of an ascending thoracic aortic aneurysm is not associated with biomechanical
weakening but with stiffening and reduction in vessel extensibility and wall elastin content.
Healthy and aneurysmal tissue exhibits similar regional heterogeneity and directional
variations in strength and stiffness. The present findings might help in the creation of a better
understanding of the pathogenesis of aneurysm dissection.
110 Outcomes of surgical intervention for isolated active mitral valve endocarditis
Amir M. Sheikh, FRCS (C/Th), MBBS, Abdelsalam M. Elhenawy, MD, PhD, Manjula Maganti, MSc,
Susan Armstrong, MSc, Tirone E. David, MD, and Christopher M. Feindel, MD, Toronto, Ontario,
Canada
Late outcomes of surgical intervention for active endocarditis isolated to the mitral valve are
undocumented. In 104 patients actuarial survival was 58% 6 6% at 10 years. Preoperative
shock, Staphylococcus aureus infection, and bioprosthesis use were independent predictors
of death. Event-free survival was greater in those with native endocarditis versus those with
nonnative endocarditis.
117 Endovascular repair of the thoracic aorta in the post-FDA approval era
Joshua D. Adams, MD, John F. Angle, MD, Alan H. Matsumoto, MD, Benjamin B. Peeler, MD,
Bulent Arslan, MD, Kenneth J. Cherry, MD, John A. Kern, MD, and Michael D. Dake, MD,
Charlottesville, Va
Indications and outcomes of the phase II multicenter trial of the Gore TAG endoprosthesis
are compared with a single institution’s first 50 consecutive patients undergoing endovascular
repair of multiple thoracic aortic diseases with this device after FDA approval and commercial
availability.
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124 Ten-year experience with handmade trileaflet polytetrafluoroethylene valved
conduit used for pulmonary reconstruction
Makoto Ando, MD, and Yukihiro Takahashi, MD, Tokyo, Japan
One hundred thirty-nine patients underwent pulmonary reconstruction with polytetrafluoroethylene
conduits. Estimated freedom from conduit explantation was 88.0%6 6.8%. Pulmonary insufficiency
was less than or equal to mild in 75.0% at 10 years, and all valves maintained their motion.
Polytetrafluoroethylene conduits are a valid option for pulmonary reconstruction.
132 Morphologic features of atrioventricular septal defect with only ventricular
component: Further observations pertinent to surgical repair
Iki Adachi, MD, Hideki Uemura, MD, FRCS, Karen P. McCarthy, BS, and Siew Yen Ho, PhD,
FRCPath, FESC, London, United Kingdom
AVSD with only a ventricular component of septal deficiency is the least common of the various
forms of this malformation. We reviewed its morphology in heart specimens and compared our
findings with the other forms for a better understanding of its surgical morphology.
139 Prospective follow-up study of children with univentricular heart:
Neurodevelopmental outcome at age 12 months
Anne Sarajuuri, MD, Tuula Lo¨nnqvist, MD, PhD, Leena Mildh, MD, PhD, Irmeli Rajantie, PT,
Marianne Eronen, MD, PhD, Ilkka Mattila, MD, PhD, and Eero Jokinen, MD, PhD, Helsinki,
Finland
At 1 year, compared with control subjects, children with hypoplastic left heart syndrome were
significantly less developed in most developmental domains, but patients with other forms of
univentricular heart were significantly less developed only in motor skills. Associated with worse
outcome were diagnosis, history of convulsions, and increased plasma lactate levels after
a bidirectional Glenn operation.
146 Impaired neuroanatomic development in infants with congenital
heart disease
Kazuhiro Watanabe, MD, Mie Matsui, MD, Junko Matsuzawa, MD, Chiaki Tanaka, MD,
Kyo Noguchi, MD, Naoki Yoshimura, MD, Kazuhisa Hongo, MD, Mayumi Ishiguro, PhD,
Sayaka Wanatabe, MD, Keiich Hirono, MD, Keiichiro Uese, MD, Fukiko Ichida, MD,
Hideki Origasa, PhD, Jun Nakazawa, MD, Yoshihiro Oshima, MD, Toshio Miyawaki, MD,
Tachiyo Matsuzaki, PhD, Toshikatsu Yagihara, MD, Warren Bilker, PhD, and Ruben. C. Gur, MD,
Toyama, Chiba, Kobe, Japan, and Philadelphia, Pa
Brain developmental impairment occurs in infants with congenital heart disease, especially in those
who have preoperative hypoxia. Underdevelopment of gray matter was apparent in the frontal lobe,
which includes the motor area, and correlated weakly with psychomotor developmental delay,
especially in infants with single ventricle physiology or transposition of the great arteries.
154 Near-infrared spectroscopy: What we know and what we need to know—A
systematic review of the congenital heart disease literature
Jennifer C. Hirsch, MD, John R. Charpie, MD, PhD, Richard G. Ohye, MD, and
James G. Gurney, PhD, Ann Arbor, Mich
NIRS technology has been described in adult and pediatric cardiac literature in multiple
clinical settings. With new technology, the potential clinical gains (and limitations) need to be
critically evaluated before integration into routine patient care. This study comprehensively
reviews the scientific literature on NIRS for patients with congenital heart disease.
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CSPEvolving Technology (ET) 160 Radiofrequency ablation for treatment of medically inoperable stage I
non–small cell lung cancer
Michael Lanuti, MD, Amita Sharma, MD, Subba R. Digumarthy, MD, Cameron D. Wright, MD,
Dean M. Donahue, MD, John C. Wain, MD, Douglas J. Mathisen, MD, and Jo-Anne O. Shepard,
MD, Boston, Mass
Radiofrequency ablation of medically unresectable early-stage lung cancer was performed in 31
patients in 5 years. Local tumor recurrence rate was 31%; 3-year local progression-free survival was
58%. Tumors larger than 3.0 cm had the highest local recurrence rate, whereas tumors smaller than
2.0 cm had the lowest.
167 Transapical transcatheter aortic valve implantation: 1-year outcome in 26
patients
Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Lukas A. Altwegg, MD,
Daniel R. Wong, MD, Ronald G. Carere, MD, Christopher R. Thompson, MD, Robert R. Moss, MD,
Brad Munt, MD, Sanjeevan Pasupati, MD, Robert H. Boone, MD, Jean-Bernard Masson, MD,
Abdullah Al Ali, MD, and John G. Webb, MD, Vancouver and British Columbia, Canada
We have completed 12 months of follow-up on the first 26 patients (age, 80 6 9 years) who
underwent transapical aortic valve implantation in our center. Thirty-day mortality was 23%. There
were no late valve-related complications. New York Heart Association functional class improved
significantly. The aortic valve area and mean gradient remained stable at 12 months.
174 Toward the development of a fully elastic mitral ring: Preliminary, acute, in vivo
evaluation of physiomechanical behavior
Paolo Ferrazzi, MD, FETCS, Attilio Iacovoni, MD, Samuele Pentiricci, MD, Michele Senni, MD,
FESC, Maria Iascone, BSc, PhD, Nicolas Borenstein, DVM, PhD, Luc Behr, DVM, PhD,
Alessandro Borghi, MEng, PhD, Rossella Balossino, MEng, PhD, and Eugenio Quaini, MD,
Bergamo and Milano, Italy, Paris, France, and London, United Kingdom
A fully elastic mitral ring device implanted in healthy sheep allows mitral dynamics in terms of area
and perimeter variations. This novel concept in annuloplasty technique appears to be promising in the
treatment of functional mitral regurgitation.
180 Restoration of left ventricular geometry and improvement of left ventricular
function in a rodent model of chronic ischemic cardiomyopathy
Jiashing Yu, BS, Karen L. Christman, PhD, Eric Chin, BS, Richard E. Sievers, BS, Maythem Saeed,
PhD, and Randall J. Lee, MD, PhD, San Francisco, Calif
This study demonstrates the application of injectable biopolymers in altering the geometry of an
aneurysmal left ventricle. The results highlight the potential of repairing chronic myocardial
infarction with an in situ tissue-engineering approach.
188 Beating-heart, off-pump mitral valve repair by implantation of artificial
chordae tendineae: An acute in vivo animal study
Pietro Bajona, MD, William E. Katz, MD, Richard C. Daly, MD, Kenton J. Zehr, MD, and
Giovanni Speziali, MD, Pittsburgh, Pa, Rochester, Minn
A new off-pump MV repair technology is tested in a porcine model of acute MR. Artificial chordae
were transapically implanted under epicardial echocardiographic guidance. Implantation of artificial
chordae through the LV apex completely eliminated MR in 4 animals and reduced it in 2.
(continued on page 30A)
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CSP194 Paracorporeal pulsatile biventricular assist device versus extracorporal
membrane oxygenation–extracorporal life support in adult fulminant
myocarditis
Olivier N. Pages, MD, Ste´phane Aubert, MD, Alain Combes, MD, PhD, Charles E. Luyt, MD,
Alain Pavie, MD, PhD, Philippe Le´ger, MD, Iradj Gandjbakhch, MD, PhD, and
Pascal Leprince, MD, PhD, Paris, France
Femorofemoral extracorporeal membrane oxygenation (ECMO) is as efficient as biventricular assist
device (BIVAD) support in first-line treatment of adult fulminant myocarditis. ECMO allows out-of-
hospital implantation after achievement of local anesthesia, and secondary transfer is safe. ECMO
facilitates quick recovery of renal and hepatic functions. Central ECMO is second-line treatment.
Cardiopulmonary
Support and Physiology
(CSP)
198 Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm
for orthotopic heart transplantation
Donna M. Rudd, MSc, and Geoffrey P. Dobson, PhD, Townsville and Queensland, Australia
A new nondepolarizing, normokalemic heart preservation solution comprising adenosine and
lidocaine in Krebs-Henseleit solution with 10-mmol/L glucose was shown to arrest the rat heart for 6
hours at 4C (static storage) or 28C to 30C intermittent flushes) with 68% to 75% spontaneous
return of cardiac output.
208 Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left
ventricular assist devices
Sheri Crow, MD, MS, Ranjit John, MD, Andrew Boyle, MD, Sara Shumway, MD, Kenneth Liao, MD,
PhD, Monica Colvin-Adams, MD, Carol Toninato, RN, Emil Missov, MD, Marc Pritzker, MD,
Cindy Martin, MD, Daniel Garry, MD, PhD, William Thomas, PhD, and Lyle Joyce, MD, PhD,
Rochester and Minneapolis, Minn
Gastrointestinal bleeding events were retrospectively reviewed for 101 recipients of left ventricular
assist devices at a single center. Patients implanted with nonpulsatile left ventricular assist devices
had a significantly higher rate of gastrointestinal bleeding events than did those with pulsatile left
ventricular assist devices.
216 Intramyocardial injection of tannic acid attenuates postinfarction remodeling:
A novel approach to stabilize the breaking extracellular matrix
Hao Zhang, MD, PhD, Shen-jun Zhu, MD, De Wang, MD, PhD, Ying-jie Wei, PhD, and
Sheng-Shou Hu, MD, Beijing, China
Myocardial infarction (MI) is associated with early matrix metalloproteinase (MMP) activation and
extracellular matrix degradation. Intramyocardial injection of tannic acid at early post-MI stage may
significantly inhibit the activity of MMP-2/-9 and increase the collagen content, thicken the scar, and
prevent infarct expansion and ventricular dilation.
223 Vagal nerve stimulation prevents reperfusion injury through inhibition of
opening of mitochondrial permeability transition pore independent of the
bradycardiac effect
Rajesh G. Katare, MD, Motonori Ando, PhD, Yoshihiko Kakinuma, MD, Mikihiko Arikawa, PhD,
Takemi Handa, MD, Fumiyasu Yamasaki, MD, and Takayuki Sato, MD, Nankoku and Okayama,
Japan
In spite of recent advances in medical therapy, reperfusion injury still provides a stiff challenge to the
cardiac surgeon. In this study we propose a novel neurally mediated approach in treating reperfusion
injury with vagal nerve stimulation.
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CSP232 Regression of pressure-induced left ventricular hypertrophy is characterized by
a distinct gene expression profile
William E. Stansfield, MD, Peter C. Charles, PhD, Ru-hang Tang, PhD, Mauricio Rojas, MD,
Rajendra Bhati, MD, Nancy C. Moss, MD, Cam Patterson, MD, and Craig H. Selzman, MD,
Chapel Hill, NC, and Salt Lake City, Utah
Minimally invasive transverse arch banding and subsequent debanding was performed to study
mechanisms independently associated with regression of left ventricular hypertrophy. Whole-
genome arrays revealed that left ventricular hypertrophy regression is more than the reverse of its
development, and is identified by a unique genomic signature.
Brief Communications:
Clinical
239 An unusual case of nonbacterial thrombotic (marantic) endocarditis
Cevher Ozcan, MD, Edward J. Miller, MD, Kerry S. Russell, MD, PhD, Michael L. Dewar, MD,
and Lynda E. Rosenfeld, MD, New Haven, Conn
Brief Communications:
Technical
242 Compressed true lumen in the innominate artery: A pitfall of right axillary
arterial perfusion in acute aortic dissection
Kazumasa Orihashi, MD, Taijiro Sueda, MD, Kenji Okada, MD, and Shinya Takahashi, MD,
Hiroshima, Japan
243 Partial left ventricular support implanted through minimal access surgery as
a bridge to cardiac transplant
Bart Meyns, MD, PhD, Filip Rega, MD, Joris Ector, MD, Walter Droogne, MD, Johan Vanhaecke,
MD, PhD, Jan Van Hemelrijck, MD, PhD, Bartley Griffith, MD, Robert Dowling, MD, Mark Zucker,
MD, and Daniel Burkhoff, MD, PhD, Leuven, Belgium, College Park, Md, Louisville, Ky, Newark,
NJ, and New York, NY
245 A bilobed thoracic outlet mass: Options for resection
Glenn McKay, MD, Vincent Arlet, MD, John A. Kern, MD, Christine L. Lau, MD, David R. Jones,
MD, and Benjamin D. Kozower, MD, Charlottesville, Va
247 Repair of acute postinfarction atrioventricular dehiscence in a patient with
posterior left ventricular aneurysm
Igor E. Konstantinov, MD, PhD, Pankaj Saxena, MCh, DNB, Shane Ling, MB, BS, and
Trenton Barrett, MB, BS, Perth, Australia
249 Video-assisted thoracoscopic bullectomy for an infectious giant bulla with the
concomitant use of the perioperative intracavity fluid suction
Yuji Taniguchi, MD, Shinji Fujioka, MD, Yoshin Adachi, MD, Ken Miwa, MD, and
Hiroshige Nakamura, MD, Yonago, Japan
251 Incomplete transmural ablation caused by bipolar radiofrequency ablation
devices
Wataru Kato, MD, Akihiko Usui, MD, Hideki Oshima, MD, Toshiaki Akita, MD, and Yuichi Ueda,
MD, Nagoya, Japan
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e1 Spontaneous rupture of the dissected coronary sinus mimicking acute
coronary syndrome
Thomas Bartel, MD, Alfred Kocher, MD, Gudrun Feuchtner, MD, Silvana Mu¨ller, MD,
Johannes O. Bonatti, MD, and Bernhard Metzler, MD, Innsbruck, Austria
e3 Lipomatous septal hypertrophy
Christina Doesch, MD, Claudia Plachtzik, MD, and Christian S. Haas, MD, Tuebingen, Germany
e4 Takotsubo cardiomyopathy after repair of ruptured abdominal aortic aneurysm
Yukio Umeda, MD, PhD, Yukihiro Matsuno, MD, PhD, Matsuhisa Imaizumi, MD, PhD, Yoshio Mori,
MD, PhD, and Hiroshi Takiya, MD, PhD, Gifu, Japan
e6 Do statins delay the progression of aortic stenosis?
Hisato Takagi, MD, PhD, Norikazu Kawai, MD, and Takuya Umemoto, MD, PhD, Shizuoka, Japan
e10 Penetrating ulcer of the aortic arch presenting with hemoptysis
Vassilios S. Avlonitis, PhD, Roger W. Bury, FRCR, Andrew J. Duncan, FRCS, and Joseph Zacharias,
FRCS, Blackpool, United Kingdom
e12 Concomitant cardiac and cerebral leiomyosarcoma: A challenge for surgical
and adjuvant therapy
Christoph A. Tschan, MD, M. Javad Mirzayan, MD, Alexandru C. Stan, MD,
Maximilian A. Pichlmaier, MD, and Joachim K. Krauss, MD, Hannover, Germany
e14 Cardiac echinococcosis of the interventricular septum in early childhood:
Report of two cases
T. Mohsen, MD, FRCS, N. El Beharry, MD, T. Maree, MD, and E. S. Akl, MD, Cairo, Egypt
e17 Successful immediate cryorecanalization of a simultaneous high-grade tracheal
and bronchial stenosis as rare manifestations of bronchial-associated lymphoid
tissue lymphoma
Christian Schumann, MD, Philipp M. Lepper, MD, Thomas F. E. Barth, MD, Peter Mo¨ller, MD, and
Stefan Kru¨ger, MD, Ulm, Germany, and Berne, Switzerland
e19 New-onset heart failure caused by spontaneous papillary muscle rupture:
Diagnosis with dual-source computed tomographic coronary angiography
Heon Lee, MD, PhD, Balazs Ruzsics, MD, PhD, U. Joseph Schoepf, MD, Edward A. Stewart, DO,
Philip Costello, MD, James L. Glenn, MD, and John S. Ikonomidis, MD, PhD, Charleston, SC, and
Seoul, Republic of Korea
e21 False aneurysm after transapical aortic valve implantation
Nawwar Al-Attar, FRCS, FETCS, PhD, Richard Raffoul, MD, Dominique Himbert, MD,
Eric Brochet, MD, Alec Vahanian, MD, FRCP, and Patrick Nataf, MD, Paris, France
e23 Extralobar pulmonary sequestration infected with Mycobacterium gordonae
Yukio Umeda, MD, PhD, Yukihiro Matsuno, MD, PhD, Matsuhisa Imaizumi, MD, PhD, Yoshio Mori,
MD, PhD, Hitoshi Iwata, MD, PhD, and Hiroshi Takiya, MD, PhD, Gifu, Japan
e25 Intrapulmonary psammomatous melanotic schwannoma
Yee-Fung Lin, MD, Sheng-Chuan Hsi, MD, Junn-Liang Chang, PhD, and Chun-Hsiung Huang, MD,
Taiwan, Republic of China
e27 Low-grade sarcoma of the right upper lobe vein mimicking a metastatic disease
Dominique Fabre, MD, Jeremie H. Lefevre, Vincent De Montpreville, Elie Fadel, Gaetano Rocco,
Olivier Chataignier, Sacha Mussot, and Philippe G. Dartevelle, Paris, France
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e30 Surgical approach to repair of ruptured chordae tendineae causing tricuspid
regurgitation
Vincent Chan, MD, Dominique Grisoli, MD, Marc Ruel, MD, MPH, John Veinot, MD, and
Thierry Mesana, MD, PhD, Ottawa, Ontario, Canada
e32 Is subtotal resection of a right ventricular fibroma a valid surgical option?
Roland Henaine, MD, Emilie Adam, MD, Kasra Azarnoush, MD, N. Yashimura, MD, PhD,
M. Cannesson, MD, A. Millon, MD, F. Lachhab, MD, and Jean Ninet, MD, PhD,
Lyon, France
e34 Simultaneous repair for aortic incompetence with annuloaortic ectasia and
pectus excavatum by modified Ravitch procedure with pectus bars in an adult
patient with Marfan syndrome
Yang Gi Ryu, MD, Man-Jong Baek, MD, Hyun Koo Kim, MD, Young Ho Choi, MD,
Young-Sang Sohn, MD, and Hark Jei Kim, MD, Seoul, Republic of Korea
e36 Mitral valve repair during bypass in a 4-year-old girl with familial Evans
syndrome
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